Global venture capital firm with a focus on early and growth-stage technology companies.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Vetigenics | 2025 | Seed | $6.0M | Philadelphia |
| Stakpak | 2025 | Pre-Seed | $500K | Wilmington |
| Cactos | 2025 | Venture - Series Unknown | $7.3M | Kempele |
| Zelt | 2025 | Series A | $6.0M | London |
| Presentations.AI | 2025 | Seed | $3.0M | Sydney |
| Swan | 2025 | Series B | $43.8M | Paris |
| Laclaree | 2025 | Seed | $3.6M | Lyon |
| Cinareo | 2025 | Pre-Seed | $1.0M | Toronto |
| Arctic Therapeutics | 2025 | Series A | $27.5M | Reykjavík |
| InRev | 2025 | Seed | $3.8M | Richmond |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 201 | Vetigenics | Seed | $6.0M | Philadelphia, United States |
| 202 | Stakpak | Pre-Seed | $500K | Wilmington, United States |
| 203 | Cactos | Venture - Series Unknown | $7.3M | Kempele, Finland |
| 204 | Zelt | Series A | $6.0M | London, United Kingdom |
| 205 | Presentations.AI | Seed | $3.0M | Sydney, Australia |
| 206 | Swan | Series B | $43.8M | Paris, France |
| 207 | Laclaree | Seed | $3.6M | Lyon, France |
| 208 | Cinareo | Pre-Seed | $1.0M | Toronto, Canada |
| 209 | Arctic Therapeutics | Series A | $27.5M | Reykjavík, Iceland |
| 210 | InRev | Seed | $3.8M | Richmond, United States |
Vetigenics discovers and develops antibody-based immunotherapies to treat cancer and chronic diseases in companion animals
Stakpak is a DevOps IDE powered by AI, helps software developers build and maintain production-ready infrastructure.
Cactos is a smart energy storage system that secures power supply locally.
Zelt is an HRtech startup that helps businesses oversee their entire workforce throughout the employee lifecycle within a single system.
Presentations.AI uses machine learning to analyse your presentation and provide feedback to help you to understand how you can improve.
Swan is a banking service platform that enables businesses to integrate embedded finance platform that integrates banking services.
Laclaree develops a pair of adaptive eyeglasses for presbyopia.
Cinareo offers omni-channel capacity planning and financial analysis tailored to multi-channel contact center settings.
Arctic Therapeutics is a drug discovery and development company that focuses on identifying genetic causes of major diseases.
inRev is a surety bond underwriter that uses proprietary technology, data, and AI to underwrite profitable surety premium.
GT Medical Technologies is a medical device company that offers innovative medical solutions for brain tumor patients.
AI-augmented, conversational care assistant delivering real-time risk and quality gap closure for Medicare Advantage providers.
World's First Independent 'SASE' Agent
SaaS, Agentic-AI, Procurement
CyGO Entrepreneurs empowers European founders to create and scale world-class cybersecurity ventures globally.
Betmate is a social betting platform allowing users to place bets against one another.
ThreatMark protects businesses from fraud using AI and behavioral intelligence.
Fermata provides computer vision solutions for the farmers to reduce crop losses and decrease the need for pesticide and chemical usage
A digital health platform designed to enhance real-world, evidence-based care while empowering individuals of their healthcare journey.
Rosalyn.ai is a software company that provides remote exam proctoring to educational institutions and certification programs.
The Future of Engineered Tissue
PulseAd is an AI-powered Connected Retail Media Platform that empowers e-commerce sellers to maximize advertising efficiency.
Alertive provide healthcare messaging to provide seamless communication for the workforce and improve patient flow
SociAbility offers an application platform that helps disabled people get better access information.
Nuitée is building Stripe for travel. Enabling businesses to swiftly develop travel applications.
Accel has invested in 3,802 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Accel's top investment sectors include Artificial Intelligence (AI), Software, SaaS, Health Care, Biotechnology. The firm invests across 73 different industry categories.
Among tracked funding rounds, GT Medical Technologies received $53.3M in a Series D round. Accel's total known invested capital is $94.5B.
Accel's average investment size is $207.1M across its portfolio of 3,802 companies.
Recent Accel portfolio additions include Vetigenics, Stakpak, Cactos, Zelt, Presentations.AI. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors